3M Company reports recurring developments across its science-based industrial, transportation and electronics, and consumer businesses. Company updates commonly cover quarterly results, guidance, margins, cash flow, portfolio reshaping, transformation costs, PFAS and litigation-related items, and capital-structure activity.
News also includes product and capacity updates tied to 3M technologies and brands, including 3M Expanded Beam Optical interconnect solutions for data centers and Scotch-Brite consumer cleaning products. Other recurring themes include investor events, board and leadership appointments, government affairs, and manufacturing investments linked to the company's global operations.
The 3M Board of Directors has declared a quarterly dividend of $1.49 per share for Q1 2022, payable on March 12, 2022, to shareholders of record on February 18, 2022. 3M has maintained uninterrupted dividend payments for over 100 years and has returned over $14 billion to shareholders in the past three years. This dividend declaration marks the 64th consecutive year of dividend increases, showcasing the company's commitment to returning value to its shareholders.
ST. PAUL, Minn., Feb. 8, 2022 /PRNewswire/ -- 3M™ M*Modal Fluency for Imaging has achieved the Best in KLAS 2022 title in the Speech Recognition Front-End, Imaging category. This AI-driven solution enhances clinical documentation and workflow for radiologists through advanced speech recognition and integrated productivity tools, ensuring accurate documentation. Garri Garrison, president of 3M Health Information Systems, emphasized the solution's ability to improve reporting speed and accuracy, affirming its competitive edge in healthcare.
Summary not available.
3M reported its fourth-quarter and full-year 2021 results, highlighting a 10% growth in overall sales for the year, amounting to $35.4 billion. In Q4, sales reached $8.6 billion, up 0.3% year-on-year, with notable increases in Consumer (4.1%) and Health Care (0.7%) segments. However, sales declined in Transportation and Electronics (1.5%) and Safety and Industrial (2.2%). The Q4 earnings per share were $2.31, a 4% decrease from the previous year. 3M returned $1.8 billion to shareholders in Q4, including $848 million in dividends.
3M (NYSE: MMM) has scheduled a Virtual Strategic Update and 2022 Outlook Meeting for February 14, 2022, from 8-11 a.m. CST. Investors can access the event via webcast or by calling (800) 762-2596 in the U.S. and +1 (212) 231-2916 internationally.
The meeting will feature presentations from key executives, including CEO Mike Roman, and will cover 3M's strategic priorities and financial outlook for 2022, concluding with a Q&A session.
On January 13, 2022, 3M announced its ongoing efforts to provide access to N95 respirators amid the surge of the Omicron variant. The company ensures that its NIOSH-approved N95 masks filter out at least 95% of airborne particles, helping to protect users against viruses. 3M is the largest N95 manufacturer in the U.S., with plants in South Dakota and Nebraska. The press release also highlights the importance of proper fit and offers resources to combat counterfeit products, having already seized over 55 million fraudulent respirators. N95s are available at major retailers and online.
3M (NYSE: MMM) announced its fourth-quarter 2021 earnings conference call scheduled for January 25, 2022, at 8 a.m. CST. Investors can join the call by dialing (800) 762-2596 in the U.S. or +1 (212) 231-2916 internationally. The conference call will be accessible via live webcast, with a replay available on 3M's Investor Relations website.
3M focuses on applying science to enhance daily lives, collaborating globally to tackle challenges and deliver innovative solutions.
Summary not available.
Summary not available.
NEOGEN Corporation (NASDAQ: NEOG) and 3M (NYSE: MMM) announced a transaction to separate 3M's Food Safety business, valued at approximately $5.3 billion, and combine it with NEOGEN. This merger aims to create a leading innovator in food safety, increasing NEOGEN’s revenue from this segment to approximately 70% of total revenue. Pro forma revenues are projected to reach $1 billion in the first full year post-closing, with anticipated synergies of $30 million in EBITDA. The transaction is expected to close by Q3 2022.